Publications by authors named "Yearin Jun"

Claim this Profile
L
Lower hepatotoxicity risk in Xelaglifam, a novel GPR40 agonist, compared to Fasiglifam for type 2 diabetes therapy.
Jongmin Yoon, Haengjin Song, Ji Soo Park, Jeong Ho Kim, Yearin Jun, Jung Woo Lee

Biomed Pharmacother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib Delivery by Quinic Acid-Conjugated Nanoparticles: Discrepancy Between Tumoral Drug Accumulation and Anticancer Efficacy in a Murine 4T1 Orthotopic Breast Cancer Model.
Yearin Jun, Jun Xu, Hyungjun Kim, Ji Eun Park, Yoo-Seong Jeong

J Pharm Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation.
Ji Eun Park, Joonyoung Park, Yearin Jun, Yunseok Oh, Gongmi Ryoo, Jung Hwan Jo

J Control Release· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins.
Jun Xu, Steve Seung-Young Lee, Howon Seo, Liang Pang, Yearin Jun

Small· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation proteasome inhibitors for cancer therapy.
Ji Eun Park, Zachary Miller, Yearin Jun, Wooin Lee, Kyung Bo Kim

Transl Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Organic Anion Transporting Polypeptide 1B1 and 1B3 by Betulinic Acid: Effects of Preincubation and Albumin in the Media.
Yunseok Oh, Yoo-Seong Jeong, Min-Soo Kim, Jee Sun Min, Gongmi Ryoo, Yearin Jun

J Pharm Sci· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis